October 31, 2019
- Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry
- Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment Guidance for Industry
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- ICU Medical, Inc. Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP and 0.9% Sodium Chloride Injection, USP Due to Presence of Particulate Matter
- FDA Drug Shortages
- Buspirone HCl Tablets (Updated - Currently in Shortage)
- Dexrazoxane Injection (Updated - Currently in Shortage)
- Divalproex Sodium Extended-Release Tablets (New - Discontinuation)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- Levetiracetam Immediate-Release Oral Tablets, USP (Updated - Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated - Currently in Shortage)
- Prednisolone Acetate 1% Ophthalmic Suspension (Updated - Resolved)
- Tacrolimus Capsules (Updated - Currently in Shortage)
- National Drug Code Directory (updated)
- NDC Database Excluded Packages and Products (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario